Clinical Spectrum and Molecular Characteristics of Inherited Ocular Diseases in a Cohort of Pediatric Patients With Infantile Nystagmus Syndrome
Investigative Ophthalmology & Visual Science · 2025
DOI: 10.1167/iovs.66.4.39 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, 2025. Verfasst von Xiaoming Gong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology and Vision Center, Akron Children's Hospital, Akron, Ohio, United States. Hauptthemen laut MEDLINE: Nystagmus, Congenital, Mutation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Purpose
Infantile nystagmus syndrome (INS), the most prevalent form of nystagmus in children, often indicates underlying ocular and neurological conditions. Genetic assessment plays a crucial role in clinical management, genetic counseling, and access to emerging gene-based therapies. This study aims to characterize the clinical and genetic landscape of inherited ocular diseases (IODs) in children with INS.
Methods
We retrospectively analyzed clinical and genetic data from 205 unrelated pediatric patients with INS enrolled in an IRB-approved nystagmus registry (2010-2024). All underwent next-generation sequencing (NGS) with targeted gene panels to detect pathogenic variants.
Results
The cohort comprised 117 males and 88 females (mean [SD] age, 8.85 [10.37] years). The most common INS-associated IODs included albinism (32%), Leber congenital amaurosis (LCA) (14%), and achromatopsia (14%). Genetic testing achieved a definitive diagnosis in 85 of 205 patients, yielding a molecular diagnostic rate of 41.5%. A total of 83 pathogenic and likely pathogenic variants were identified across 30 genes. The seven most frequently disease-causing genes-TYR, CNGB3, RPGR, GPR143, ABCA4, OCA2 and FRMD7-accounted for 65% of the genetically solved cases. Additionally, eight genes associated with LCA (AIPL1, CABP4, GUCY2D, IMPDH1, NMNAT1, RDH12, PRPH2, and RPGRIP1) contributed to 15% of these cases.
Conclusions
This study underscores the utility of NGS in diagnosing INS-associated IODs, providing essential insights for targeted interventions and identifying patients as candidates potentially eligible for ongoing gene-based therapy clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology and Vision Center, Akron Children's Hospital, Akron, Ohio, United States.
- Vision Center of Excellence, Rebecca D. Considine Research Institute, Akron Children's Hospital, Akron, Ohio, United States.
- College of Medicine, Northeast Ohio Medical University, Rootstown, Ohio, United States.
Zitieren
APA
Gong, X., Boydstun, I. P., Lawhon, W. T., Hanna, N. N., Wall, P. B., Flickinger, A., Hartmann, E. E., & Hertle, R. W. (2025). Clinical Spectrum and Molecular Characteristics of Inherited Ocular Diseases in a Cohort of Pediatric Patients With Infantile Nystagmus Syndrome. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.66.4.39
Vancouver
Gong X, Boydstun IP, Lawhon WT, Hanna NN, Wall PB, Flickinger A, et al. Clinical Spectrum and Molecular Characteristics of Inherited Ocular Diseases in a Cohort of Pediatric Patients With Infantile Nystagmus Syndrome. Investigative Ophthalmology & Visual Science. 2025. doi:10.1167/iovs.66.4.39
BibTeX
@article{Gong2025,
author = {Gong, Xiaoming and Boydstun, Ian P and Lawhon, William T and Hanna, Nancy N and Wall, Palak B and Flickinger, Aaron and Hartmann, E Eugenie and Hertle, Richard W},
title = {Clinical Spectrum and Molecular Characteristics of Inherited Ocular Diseases in a Cohort of Pediatric Patients With Infantile Nystagmus Syndrome},
journal = {Investigative Ophthalmology & Visual Science},
year = {2025},
doi = {10.1167/iovs.66.4.39}
}
EUVIMED